GRAIL, Inc. (GRAL)
NASDAQ
Real-time Data
01:30 PM
Day's Range
130.6252 wk Range
41.50Overview - GRAL - GRAIL, Inc.
Key Statistics
Valuation
Enterprise Value
5.62B
P/E (Trailing)
‪-12.89‬
P/E (Forward)
‪-17.38‬
PEG Ratio
‪0.66‬
Price / Sales (TTM)
‪38.71‬
Price / Book
‪2.51‬
EV / EBITDA
‪-14.87‬
Profitability
Gross Margin
‪-28.12%‬
Profit Margin
‪-236.94%‬
Operating Margin
‪-331.99%‬
Return on Assets
‪-12.03%‬
Return on Equity
‪-16.12%‬
Ownership
Shares Outstanding
44.66M
Float
34.34M
Short % of Shares Outstanding
‪19.47%‬
Held by Insiders
‪4.99%‬
Held by Institutions
‪86.26%‬
Price stats
Beta
‪3.25‬
50-Day Avg
‪84.83‬
200-Day Avg
‪73.68‬
Analyst Consensus
11 analysts
Average price target
‪$ 72.38‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GRAL - GRAIL, Inc.
Peers - GRAL - GRAIL, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- GRALNASDAQGRAIL, Inc.6.39BMarket Cap+56.93%52-week change-12.90P/E (Trailing)‪-236.94%‬Profit Margin
- NTRANASDAQNatera, Inc.59.14BMarket Cap+58.48%52-week change-269.84P/E (Trailing)‪-7.10%‬Profit Margin
- ILMNNASDAQIllumina Inc.41.22BMarket Cap+63.00%52-week change50.85P/E (Trailing)‪18.33%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.40.83BMarket Cap-21.10%52-week change37.14P/E (Trailing)‪25.03%‬Profit Margin
- GHNASDAQGuardant Health Inc.23.86BMarket Cap+64.35%52-week change-53.55P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings, Inc.16.86BMarket Cap+14.16%52-week change35.48P/E (Trailing)‪17.66%‬Profit Margin
- ICLRNASDAQICON plc12.50BMarket Cap-17.51%52-week change170.58P/E (Trailing)‪0.32%‬Profit Margin
Profile Summary - GRAL - GRAIL, Inc.
About
GRAIL, Inc. is a commercial-stage healthcare company focused on multi-cancer early detection testing and services. Its core offering is Galleri, a blood-based screening test designed to detect multiple cancer types before symptoms appear, supporting earlier clinical evaluation and diagnosis. The company uses…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
